$MOH
MOLINA HEALTHCARE, INC. Stock $moh

$moh Overview Financials Valuation SEC Filings Company Website

2014 Q4 Form 10-Q Financial Statement

#000117992914000020 Filed on October 30, 2014

Income Statement

Concept	2014 Q4	2014 Q3	2013 Q3
Revenue	$2.801B	$2.484B	$1.687B
YoY Change	64.22%	47.26%	9.54%
Cost Of Revenue	$2.362B	$2.138B	$1.423B
YoY Change	62.12%	50.21%	4.89%
Gross Profit	$439.5M	$346.4M	$263.8M
YoY Change	76.51%	31.31%	44.0%
Gross Profit Margin	15.69%	13.94%	15.64%
Selling, General & Admin	$318.0M	$282.4M	$220.0M
YoY Change	37.42%	28.36%	33.41%
% of Gross Profit	72.35%	81.52%	83.4%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$34.90M	$33.80M	$24.13M
YoY Change	34.75%	40.09%	18.98%
% of Gross Profit	7.94%	9.76%	9.15%
Operating Expenses	$343.0M	$306.7M	$238.9M
YoY Change	36.27%	28.38%	32.13%
Operating Profit	$97.00M	$40.00M	$24.93M
YoY Change	-3692.59%	60.48%	952.62%
Interest Expense	-$14.60M	$14.42M	$13.53M
YoY Change	5.8%	6.55%	213.6%
% of Operating Profit	-15.05%	36.05%	54.29%
Other Income/Expense, Net	$0.00	-$15.28M	-$13.51M
YoY Change		13.13%	200.24%
Pretax Income	$81.90M	$24.50M	$11.42M
YoY Change	-596.36%	114.55%	-635.8%
Income Tax	$47.90M	$8.427M	$3.865M
% Of Pretax Income	58.49%	34.4%	33.85%
Net Earnings	$34.00M	$16.00M	$7.569M
YoY Change	-472.56%	111.39%	125.0%
Net Earnings / Revenue	1.21%	0.64%	0.45%
Basic Earnings Per Share	$0.70	$0.34	$0.17
Diluted Earnings Per Share	$0.69	$0.33	$0.16
COMMON SHARES
Basic Shares Outstanding	48.40M shares	46.99M shares	45.70M shares
Diluted Shares Outstanding		48.64M shares	47.06M shares

Balance Sheet

Concept	2014 Q4	2014 Q3	2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.558B	$2.441B	$1.592B
YoY Change	56.08%	53.38%	48.42%
Cash & Equivalents	$1.539B	$1.599B	$856.6M
Short-Term Investments	$1.019B	$842.7M	$735.2M
Other Short-Term Assets	$50.88M	$82.06M	$50.06M
YoY Change	19.77%	63.92%	66.86%
Inventory
Prepaid Expenses
Receivables	$596.0M	$425.7M	$294.0M
Other Receivables	$0.00	$7.700M	$0.00
Total Short-Term Assets	$3.203B	$2.988B	$1.966B
YoY Change	57.04%	51.94%	49.6%
LONG-TERM ASSETS
Property, Plant & Equipment	$341.0M	$328.5M	$267.3M
YoY Change	16.75%	22.92%	26.69%
Goodwill	$272.0M	$236.6M	$230.8M
YoY Change	17.88%	2.54%	52.75%
Intangibles
YoY Change
Long-Term Investments			$11.70M
YoY Change			-13.33%
Other Assets	$30.00M	$51.11M	$35.74M
YoY Change	-35.43%	43.02%	77.81%
Total Long-Term Assets	$1.232B	$1.069B	$958.9M
YoY Change	29.91%	11.45%	61.77%
TOTAL ASSETS
Total Short-Term Assets	$3.203B	$2.988B	$1.966B
Total Long-Term Assets	$1.232B	$1.069B	$958.9M
Total Assets	$4.435B	$4.056B	$2.925B
YoY Change	48.43%	38.67%	53.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$242.0M	$609.4M	$282.7M
YoY Change	-24.38%	115.56%	87.22%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$11.93M	$109.0K
YoY Change	-100.0%	10842.2%	-90.46%
Total Short-Term Liabilities	$2.175B	$1.936B	$1.045B
YoY Change	68.09%	85.19%	25.66%
LONG-TERM LIABILITIES
Long-Term Debt	$887.0M	$896.9M	$770.1M
YoY Change	47.12%	16.47%	195.57%
Other Long-Term Liabilities	$34.00M	$28.30M	$25.15M
YoY Change	29.03%	12.52%	13.8%
Total Long-Term Liabilities	$921.0M	$28.30M	$25.15M
YoY Change	3395.12%	12.52%	-91.1%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.175B	$1.936B	$1.045B
Total Long-Term Liabilities	$921.0M	$28.30M	$25.15M
Total Liabilities	$3.425B	$3.092B	$2.032B
YoY Change	62.32%	52.14%	76.4%
SHAREHOLDERS EQUITY
Retained Earnings	$615.0M	$581.6M	$562.3M
YoY Change	11.19%	3.43%	18.48%
Common Stock	$396.0M	$383.3M	$332.0M
YoY Change	16.18%	15.47%	18.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)			$0.00
YoY Change
Treasury Stock Shares			0.000 shares
Shareholders Equity	$1.010B	$964.3M	$892.8M
YoY Change
Total Liabilities & Shareholders Equity	$4.435B	$4.056B	$2.925B
YoY Change	47.69%	38.67%	53.38%

Cashflow Statement

Concept	2014 Q4	2014 Q3	2013 Q3
OPERATING ACTIVITIES
Net Income	$34.00M	$16.00M	$7.569M
YoY Change	-472.56%	111.39%	125.0%
Depreciation, Depletion And Amortization	$34.90M	$33.80M	$24.13M
YoY Change	34.75%	40.09%	18.98%
Cash From Operating Activities	$219.1M	$605.7M	$223.4M
YoY Change	179.46%	171.13%	697.86%
INVESTING ACTIVITIES
Capital Expenditures	-$43.10M	-$34.10M	-$29.20M
YoY Change	28.27%	16.78%	52.08%
Acquisitions
YoY Change
Other Investing Activities	-$231.3M	-$124.8M	-$80.40M
YoY Change	-829.65%	55.22%	688.24%
Cash From Investing Activities	-$274.4M	-$159.0M	-$109.6M
YoY Change	14342.11%	45.07%	271.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$50.00M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-4.200M	124.5M	0.000
YoY Change	-244.83%		-100.0%
NET CHANGE
Cash From Operating Activities	219.1M	605.7M	223.4M
Cash From Investing Activities	-274.4M	-159.0M	-109.6M
Cash From Financing Activities	-4.200M	124.5M	0.000
Net Change In Cash	-59.50M	571.2M	113.8M
YoY Change	-174.94%	401.93%	-1072.65%
FREE CASH FLOW
Cash From Operating Activities	$219.1M	$605.7M	$223.4M
Capital Expenditures	-$43.10M	-$34.10M	-$29.20M
Free Cash Flow	$262.2M	$639.8M	$252.6M
YoY Change	134.11%	153.29%	435.17%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	383300000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	20654000	USD
CY2013Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	319965000	USD
CY2014Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	609444000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1086000	USD
CY2014Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-617000	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	340848000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16115000	USD
CY2013Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8504000	USD
CY2014Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5659000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	19183000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	15747000	USD
CY2014Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6455000	USD
CY2013Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6059000	USD
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.15
CY2014Q3	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	717000000	USD
CY2013Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	608000000	USD
CY2014Q3	us-gaap	Assets Assets	4056140000	USD
CY2013Q4	us-gaap	Assets Assets	3002937000	USD
CY2014Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	956000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	2039664000	USD
CY2014Q3	us-gaap	Assets Current AssetsCurrent	2987520000	USD
CY2014Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	850569000	USD
CY2013Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	715702000	USD
CY2014Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	849574000	USD
CY2013Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	713950000	USD
CY2014Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	659000	USD
CY2013Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	613000	USD
CY2014Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1654000	USD
CY2013Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2365000	USD
CY2013Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	1049000	USD
CY2014Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	698000	USD
CY2013Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1316000	USD
CY2013Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	306531000	USD
CY2014Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	375838000	USD
CY2013Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	44529000	USD
CY2014Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	73659000	USD
CY2014Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	530920000	USD
CY2014Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	530190000	USD
CY2014Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	7200000	USD
CY2014Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	6891000	USD
CY2014Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	312449000	USD
CY2014Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	312493000	USD
CY2014Q3	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	849574000	USD
	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	59947000	USD
	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	0	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1598596000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	935895000	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	856556000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	795770000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	662701000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	60786000	USD
CY2014Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	53.8475
CY2014Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45871000	shares
CY2014Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48279000	shares
CY2013Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	46000	USD
CY2014Q3	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	48000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	28900000	USD
CY2013Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8863000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	61101000	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	15465000	USD
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	13841000	USD
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	19222000	USD
CY2014Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	697210000	USD
CY2013Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	416368000	USD
CY2014Q3	us-gaap	Costs And Expenses CostsAndExpenses	2444572000	USD
CY2013Q3	us-gaap	Costs And Expenses CostsAndExpenses	1662153000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	4744067000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	6769160000	USD
CY2014Q3	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear	51179000	USD
CY2013Q4	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear	45675000	USD
CY2014Q3	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	1700000	shares
	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	13490236	shares
CY2014Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	707659000	USD
CY2013Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	598240000	USD
CY2013Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	737000000	USD
CY2014Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	862000000	USD
CY2014Q3	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	154341000	USD
CY2013Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	138760000	USD
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	122216000	USD
CY2014Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	190856000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	26556000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	30817000	USD
CY2014Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	7719000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	580000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	67835000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	52449000	USD
CY2013Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	18871000	USD
CY2014Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	24242000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	99464000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	68035000	USD
CY2013Q4	us-gaap	Derivative Assets DerivativeAssets	186351000	USD
CY2014Q3	us-gaap	Derivative Assets DerivativeAssets	222997000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	8000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-3383000	USD
CY2014Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	222877000	USD
CY2013Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	186239000	USD
	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	-10000000	USD
	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	-300000	USD
CY2013Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	27092000	USD
CY2014Q3	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	39258000	USD
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.61
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.36
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.33
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.59
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.33
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y
	us-gaap	Escrow Deposit Disbursements Related To Property Acquisition1 EscrowDepositDisbursementsRelatedToPropertyAcquisition1	332000	USD
	us-gaap	Escrow Deposit Disbursements Related To Property Acquisition1 EscrowDepositDisbursementsRelatedToPropertyAcquisition1	0	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	7500000	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	121845000	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	85035000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	98871000	USD
CY2013Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	176233000	USD
CY2014Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	178879000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	478990000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	560205000	USD
CY2013Q4	us-gaap	Goodwill Goodwill	230738000	USD
CY2014Q3	us-gaap	Goodwill Goodwill	236635000	USD
CY2014Q3	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	2327000	USD
	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	8523000	USD
CY2013Q3	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	5860000	USD
	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	16476000	USD
CY2014Q3	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	2316759000	USD
	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	4583818000	USD
	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	6424238000	USD
CY2013Q3	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	1584656000	USD
CY2014Q3	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	93119000	USD
CY2014Q3	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	312000	USD
CY2014Q3	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount	312000	USD
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.62
CY2014Q3	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue	92817000	USD
CY2014Q3	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount	92807000	USD
CY2014Q3	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	93129000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	53871000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	16070000	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	7553000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	28645000	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	11418000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	53429000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	97662000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	24497000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.34
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.18
CY2013Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.17
CY2013Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.16
CY2014Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.33
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.60
CY2013Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	16000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-214000	USD
CY2014Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	52000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	8184000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.18
CY2013Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2014Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.01
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.18
CY2014Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2013Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	43791000	USD
CY2013Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3865000	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8427000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24784000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	72156000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	7991000	USD
CY2013Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	32742000	USD
CY2014Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	7679000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	314391000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	20991000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1012000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	25063000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	10705000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	38442000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	68640000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-17410000	USD
	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	138176000	USD
	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	454059000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	51582000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	27552000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	126748000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	144285000	USD
	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	24301000	USD
	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	21124000	USD
CY2013Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	910000	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	1212000	shares
CY2014Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	1288000	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	527000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	532000	shares
CY2013Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	453000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	441000	shares
CY2014Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	365000	shares
CY2013Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	1740000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	4884000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	5615000	USD
CY2014Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	2041000	USD
CY2013Q3	us-gaap	Interest Expense InterestExpense	13532000	USD
CY2014Q3	us-gaap	Interest Expense InterestExpense	14419000	USD
	us-gaap	Interest Expense InterestExpense	42234000	USD
	us-gaap	Interest Expense InterestExpense	38236000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	28915000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	24874000	USD
CY2013Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	9359000	USD
CY2014Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	9587000	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	9127000	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	9732000	USD
CY2014Q3	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	3132000	USD
CY2013Q3	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	3300000	USD
	us-gaap	Interest Paid InterestPaid	24384000	USD
	us-gaap	Interest Paid InterestPaid	28035000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1293976000	USD
CY2014Q3	us-gaap	Liabilities Liabilities	3091849000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	2110000000	USD
CY2014Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4056140000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3002937000	USD
CY2014Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1936073000	USD
CY2013Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	669787000	USD
CY2014Q3	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	1123846000	USD
CY2012Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	494530000	USD
	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	4841429000	USD
CY2013	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	4932195000	USD
	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	443539000	USD
CY2013	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	385479000	USD
CY2013Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount	424173000	USD
CY2014Q3	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount	796433000	USD
CY2013	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	5381664000	USD
	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	5754371000	USD
CY2014Q3	us-gaap	Long Term Debt LongTermDebt	862000000	USD
CY2013Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	182008000	USD
CY2014Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	11927000	USD
CY2014Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	851551000	USD
CY2014Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2014Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2014Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2014Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2014Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	10449000	USD
CY2014Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	842683000	USD
CY2013Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	703052000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	490458000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	82783000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-541416000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-261280000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	841198000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	111744000	USD
	us-gaap	Net Income Loss NetIncomeLoss	62055000	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	7569000	USD
	us-gaap	Net Income Loss NetIncomeLoss	28431000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	16122000	USD
CY2013Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13508000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-43044000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-41583000	USD
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-15282000	USD
	us-gaap	Notes Issued1 NotesIssued1	0	USD
	us-gaap	Notes Issued1 NotesIssued1	176551000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
	us-gaap	Operating Income Loss OperatingIncomeLoss	96473000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	139245000	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	24926000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	39779000	USD
CY2013Q4	us-gaap	Other Assets Current OtherAssetsCurrent	42484000	USD
CY2014Q3	us-gaap	Other Assets Current OtherAssetsCurrent	82062000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	46462000	USD
CY2014Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	51108000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	500000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-954000	USD
CY2013Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1294000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	469000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-657000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-1539000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	756000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-1061000	USD
CY2013Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	2087000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	287000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-585000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-404000	USD
CY2013Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	793000	USD
CY2014Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	28300000	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	26351000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-810000	USD
CY2013Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	24000	USD
CY2014Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-863000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3347000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	14406000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	3875000	USD
CY2014Q3	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	-7000000	USD
	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	0	USD
	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	149331000	USD
	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	5284968000	USD
CY2013	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	5317674000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1971000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	15220000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	50000000	USD
	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	50349000	USD
	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	57684000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	7500000	USD
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	71771000	USD
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	64426000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	616324000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	627953000	USD
CY2014Q3	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	2097836000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	5753793000	USD
CY2013Q3	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	1383213000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	3965834000	USD
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2014Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q3	us-gaap	Premiums And Other Receivables Net PremiumsAndOtherReceivablesNet	3600000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	537973000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	123387000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	5156000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	7628000	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	75074000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	363000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	2117000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	473836000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	227800000	USD
CY2014Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	328547000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	292083000	USD
CY2014Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	425683000	USD
CY2013Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	298935000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	47471000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	40000000	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	USD
CY2014Q3	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	374300000	USD
CY2013Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	365200000	USD
CY2013Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	63093000	USD
CY2014Q3	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	93119000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	553129000	USD
CY2014Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	581560000	USD
CY2013Q3	us-gaap	Revenues Revenues	1687079000	USD
CY2014Q3	us-gaap	Revenues Revenues	2484351000	USD
	us-gaap	Revenues Revenues	6865633000	USD
	us-gaap	Revenues Revenues	4883312000	USD
	us-gaap	Sale Leaseback Transaction Gross Proceeds Financing Activities SaleLeasebackTransactionGrossProceedsFinancingActivities	158694000	USD
	us-gaap	Sale Leaseback Transaction Gross Proceeds Financing Activities SaleLeasebackTransactionGrossProceedsFinancingActivities	0	USD
	us-gaap	Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides the details of our medical claims and benefits payable (including amounts payable for the provision of long-term services and supports, or LTSS) as of the dates indicated:</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, <br clear="none"/>2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fee-for-service claims incurred but not paid (IBNP)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">796,433</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">424,173</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pharmacy payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62,322</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,037</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capitation payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,535</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,267</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">233,556</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180,310</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,123,846</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">669,787</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>
	us-gaap	Share Based Compensation ShareBasedCompensation	20654000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	16115000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	19300000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	22500000	USD
CY2012Q4	us-gaap	Shares Outstanding SharesOutstanding	46762000	shares
CY2013Q4	us-gaap	Shares Outstanding SharesOutstanding	45871000	shares
CY2013Q2	us-gaap	Shares Outstanding SharesOutstanding	45683000	shares
CY2014Q2	us-gaap	Shares Outstanding SharesOutstanding	46494000	shares
CY2014Q3	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	100000	USD
CY2014Q3	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	798000000	USD
	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	643000	shares
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	25000000	USD
CY2014Q3	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Required StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired	413000000	USD
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	8595000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	17500000	USD
CY2013Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	USD
CY2014Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	47300000	USD
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	6667000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	892937000	USD
CY2014Q3	us-gaap	Stockholders Equity StockholdersEquity	964291000	USD
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	71400000	USD
	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	3882000	USD
	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	0	USD
CY2013	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	5434443000	USD
	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	5795404000	USD
CY2013	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-52779000	USD
	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-41033000	USD
	us-gaap	Technology Services Costs TechnologyServicesCosts	119188000	USD
	us-gaap	Technology Services Costs TechnologyServicesCosts	117831000	USD
CY2014Q3	us-gaap	Technology Services Costs TechnologyServicesCosts	40067000	USD
CY2013Q3	us-gaap	Technology Services Costs TechnologyServicesCosts	40113000	USD
CY2013Q3	us-gaap	Technology Services Revenue TechnologyServicesRevenue	51100000	USD
	us-gaap	Technology Services Revenue TechnologyServicesRevenue	156419000	USD
	us-gaap	Technology Services Revenue TechnologyServicesRevenue	150528000	USD
CY2014Q3	us-gaap	Technology Services Revenue TechnologyServicesRevenue	52557000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	8000000	USD
CY2014Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1800000	USD
	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	6200000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	5700000	USD
CY2014Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	1600000	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48088000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46767000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48644000	shares
CY2013Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47062000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46991000	shares
CY2013Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45699000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46435000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45708000	shares
	moh	Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation	20195000	USD
	moh	Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation	16128000	USD
CY2014Q3	moh	Anticipated Medicare Risk Adjustment Premiums AnticipatedMedicareRiskAdjustmentPremiums	18600000	USD
CY2013Q4	moh	Anticipated Medicare Risk Adjustment Premiums AnticipatedMedicareRiskAdjustmentPremiums	20800000	USD
CY2013Q4	moh	Available For Sale Securities In Unrealized Loss Position Less Than Twelve Months Qualitative Disclosure Number Of Positions AvailableForSaleSecuritiesInUnrealizedLossPositionLessThanTwelveMonthsQualitativeDisclosureNumberOfPositions	174	Security
CY2014Q3	moh	Available For Sale Securities In Unrealized Loss Position Less Than Twelve Months Qualitative Disclosure Number Of Positions AvailableForSaleSecuritiesInUnrealizedLossPositionLessThanTwelveMonthsQualitativeDisclosureNumberOfPositions	279	Security
CY2013Q4	moh	Available For Sale Securities In Unrealized Loss Position Twelve Months Or More Qualitative Disclosure Number Of Positions AvailableForSaleSecuritiesInUnrealizedLossPositionTwelveMonthsOrMoreQualitativeDisclosureNumberOfPositions	57	Security
CY2014Q3	moh	Available For Sale Securities In Unrealized Loss Position Twelve Months Or More Qualitative Disclosure Number Of Positions AvailableForSaleSecuritiesInUnrealizedLossPositionTwelveMonthsOrMoreQualitativeDisclosureNumberOfPositions	45	Security
CY2013Q4	moh	Capitation Claims Payable CapitationClaimsPayable	20267000	USD
CY2014Q3	moh	Capitation Claims Payable CapitationClaimsPayable	31535000	USD
	moh	Class Of Warrant Or Right Trading Days Measurement Period ClassOfWarrantOrRightTradingDaysMeasurementPeriod	P160D
CY2014Q3	moh	Health Care Organization Insurer Fee Expense HealthCareOrganizationInsurerFeeExpense	22308000	USD
CY2013Q3	moh	Health Care Organization Insurer Fee Expense HealthCareOrganizationInsurerFeeExpense	0	USD
	moh	Health Care Organization Insurer Fee Expense HealthCareOrganizationInsurerFeeExpense	0	USD
	moh	Health Care Organization Insurer Fee Expense HealthCareOrganizationInsurerFeeExpense	66443000	USD
CY2013Q3	moh	Health Care Organization Insurer Fee Revenue HealthCareOrganizationInsurerFeeRevenue	0	USD
	moh	Health Care Organization Insurer Fee Revenue HealthCareOrganizationInsurerFeeRevenue	67785000	USD
CY2014Q3	moh	Health Care Organization Insurer Fee Revenue HealthCareOrganizationInsurerFeeRevenue	29427000	USD
	moh	Health Care Organization Insurer Fee Revenue HealthCareOrganizationInsurerFeeRevenue	0	USD
	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	203053000	USD
CY2014Q3	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	81240000	USD
CY2013Q3	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	43723000	USD
	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	127606000	USD
CY2014Q3	moh	Health Insurers Aca Fees Liability Estimated Annual Liabilityin Current Year HealthInsurersACAFeesLiabilityEstimatedAnnualLiabilityinCurrentYear	88600000	USD
CY2014Q3	moh	Impactof Other Tax Expense Benefiton Earnings Per Share Diluted ImpactofOtherTaxExpenseBenefitonEarningsPerShareDiluted	-0.15
CY2013Q4	moh	Lease Financing Obligations Noncurrent LeaseFinancingObligationsNoncurrent	159394000	USD
CY2014Q3	moh	Lease Financing Obligations Noncurrent LeaseFinancingObligationsNoncurrent	160412000	USD
	moh	Maximum Period For Member Risk Scores And Member Pharmacy Cost Experience After Original Year Of Service MaximumPeriodForMemberRiskScoresAndMemberPharmacyCostExperienceAfterOriginalYearOfService	P2Y
	moh	Medical Claimsand Benefits Payable Adjustments Changein Provider MedicalClaimsandBenefitsPayableAdjustmentsChangeinProvider	-15344000	USD
CY2013	moh	Medical Claimsand Benefits Payable Adjustments Changein Provider MedicalClaimsandBenefitsPayableAdjustmentsChangeinProvider	111267000	USD
CY2013Q4	moh	Other Claims Payable OtherClaimsPayable	180310000	USD
CY2014Q3	moh	Other Claims Payable OtherClaimsPayable	233556000	USD
CY2013Q4	moh	Other Claims Payable Non Risk Provider OtherClaimsPayableNonRiskProvider	151300000	USD
CY2014Q3	moh	Other Claims Payable Non Risk Provider OtherClaimsPayableNonRiskProvider	136000000	USD
CY2013Q4	moh	Pharmacy Claims Payable PharmacyClaimsPayable	45037000	USD
CY2014Q3	moh	Pharmacy Claims Payable PharmacyClaimsPayable	62322000	USD
CY2013	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.107
	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.061
	moh	Policy Holder Medical Care Cost Prior Year Percentage PolicyHolderMedicalCareCostPriorYearPercentage	0.006
CY2013	moh	Policy Holder Medical Care Cost Prior Year Percentage PolicyHolderMedicalCareCostPriorYearPercentage	0.010
CY2013	moh	Policy Holder Premium Revenue Prior Year Percentage PolicyHolderPremiumRevenuePriorYearPercentage	0.009
	moh	Policy Holder Premium Revenue Prior Year Percentage PolicyHolderPremiumRevenuePriorYearPercentage	0.005
	moh	Weighted Average Numberof Shares Issued Exchangeof Debt Instruments WeightedAverageNumberofSharesIssuedExchangeofDebtInstruments	0	shares
CY2014Q3	moh	Weighted Average Numberof Shares Issued Exchangeof Debt Instruments WeightedAverageNumberofSharesIssuedExchangeofDebtInstruments	460000	shares
	dei	Document Type DocumentType	10-Q
CY2013Q3	moh	Weighted Average Numberof Shares Issued WeightedAverageNumberofSharesIssued	16000	shares
	moh	Weighted Average Numberof Shares Issued WeightedAverageNumberofSharesIssued	409000	shares
	dei	Entity Central Index Key EntityCentralIndexKey	0001179929
	moh	Weighted Average Numberof Shares Issued Exchangeof Debt Instruments WeightedAverageNumberofSharesIssuedExchangeofDebtInstruments	155000	shares
CY2013Q3	moh	Weighted Average Numberof Shares Issued Exchangeof Debt Instruments WeightedAverageNumberofSharesIssuedExchangeofDebtInstruments	0	shares
	dei	Amendment Flag AmendmentFlag	false
	moh	Weighted Average Numberof Shares Issued WeightedAverageNumberofSharesIssued	321000	shares
CY2013Q3	moh	Premium Tax Expenses PremiumTaxExpenses	43723000	USD
	moh	Premium Tax Expenses PremiumTaxExpenses	203053000	USD
CY2014Q3	moh	Premium Tax Expenses PremiumTaxExpenses	81240000	USD
	moh	Premium Tax Expenses PremiumTaxExpenses	127606000	USD
	moh	Retirement Of Treasury Stock RetirementOfTreasuryStock	53000000	USD
	moh	Retirement Of Treasury Stock RetirementOfTreasuryStock	0	USD
	moh	Sharebased Compensation Arrangementby Sharebased Payment Award Equity Instruments Other Than Options Grantedin Period Fair Value SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedinPeriodFairValue	24800000	USD
	moh	Sharebased Compensation Arrangementby Sharebased Payment Award Equity Instruments Other Than Options Grantedin Period Fair Value SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedinPeriodFairValue	33300000	USD
CY2013Q3	moh	Weighted Average Numberof Shares Common Stock Repurchased WeightedAverageNumberofSharesCommonStockRepurchased	0	shares
	moh	Weighted Average Numberof Shares Common Stock Repurchased WeightedAverageNumberofSharesCommonStockRepurchased	1375000	shares
CY2014Q3	moh	Weighted Average Numberof Shares Common Stock Repurchased WeightedAverageNumberofSharesCommonStockRepurchased	0	shares
	moh	Weighted Average Numberof Shares Common Stock Repurchased WeightedAverageNumberofSharesCommonStockRepurchased	0	shares
CY2014Q3	moh	Weighted Average Numberof Shares Issued WeightedAverageNumberofSharesIssued	37000	shares
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Period End Date DocumentPeriodEndDate	2014-09-30
CY2014Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	48397000	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	MOLINA HEALTHCARE INC
	dei	Trading Symbol TradingSymbol	moh

Files In Submission

Name	View Source	Status
0001179929-14-000020-index-headers.html	Edgar Link	pending
0001179929-14-000020-index.html	Edgar Link	pending
0001179929-14-000020.txt	Edgar Link	pending
0001179929-14-000020-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
moh-20140930.xml	Edgar Link	completed
moh-20140930.xsd	Edgar Link	pending
moh-20140930x10q.htm	Edgar Link	pending
moh-20140930_cal.xml	Edgar Link	unprocessable
moh-20140930_def.xml	Edgar Link	unprocessable
moh-20140930_lab.xml	Edgar Link	unprocessable
moh-20140930_pre.xml	Edgar Link	unprocessable
moh-2014x09x30xex311.htm	Edgar Link	pending
moh-2014x09x30xex312.htm	Edgar Link	pending
moh-2014x09x30xex321.htm	Edgar Link	pending
moh-2014x09x30xex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MOH
MOLINA HEALTHCARE, INC. Stock $moh

2014 Q4 Form 10-Q Financial Statement

#000117992914000020 Filed on October 30, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOH MOLINA HEALTHCARE, INC. Stock $moh

2014 Q4 Form 10-Q Financial Statement

#000117992914000020 Filed on October 30, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOH
MOLINA HEALTHCARE, INC. Stock $moh